pubmed-article:20820138 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20820138 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:20820138 | lifeskim:mentions | umls-concept:C1960048 | lld:lifeskim |
pubmed-article:20820138 | lifeskim:mentions | umls-concept:C0966225 | lld:lifeskim |
pubmed-article:20820138 | lifeskim:mentions | umls-concept:C1527144 | lld:lifeskim |
pubmed-article:20820138 | pubmed:issue | 8 | lld:pubmed |
pubmed-article:20820138 | pubmed:dateCreated | 2010-9-7 | lld:pubmed |
pubmed-article:20820138 | pubmed:abstractText | Therapeutic effect of omalizumab was studied in Japanese patients with severe asthma. | lld:pubmed |
pubmed-article:20820138 | pubmed:language | jpn | lld:pubmed |
pubmed-article:20820138 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20820138 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20820138 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20820138 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20820138 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20820138 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20820138 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20820138 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20820138 | pubmed:month | Aug | lld:pubmed |
pubmed-article:20820138 | pubmed:issn | 0021-4884 | lld:pubmed |
pubmed-article:20820138 | pubmed:author | pubmed-author:KatayamaYukoY | lld:pubmed |
pubmed-article:20820138 | pubmed:author | pubmed-author:KitaHideoH | lld:pubmed |
pubmed-article:20820138 | pubmed:author | pubmed-author:KanemitsuYosh... | lld:pubmed |
pubmed-article:20820138 | pubmed:author | pubmed-author:FuseyaYoshino... | lld:pubmed |
pubmed-article:20820138 | pubmed:author | pubmed-author:TanimuraKazuy... | lld:pubmed |
pubmed-article:20820138 | pubmed:author | pubmed-author:NisiharaYumiY | lld:pubmed |
pubmed-article:20820138 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:20820138 | pubmed:volume | 59 | lld:pubmed |
pubmed-article:20820138 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20820138 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20820138 | pubmed:pagination | 965-73 | lld:pubmed |
pubmed-article:20820138 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:20820138 | pubmed:meshHeading | pubmed-meshheading:20820138... | lld:pubmed |
pubmed-article:20820138 | pubmed:meshHeading | pubmed-meshheading:20820138... | lld:pubmed |
pubmed-article:20820138 | pubmed:meshHeading | pubmed-meshheading:20820138... | lld:pubmed |
pubmed-article:20820138 | pubmed:meshHeading | pubmed-meshheading:20820138... | lld:pubmed |
pubmed-article:20820138 | pubmed:meshHeading | pubmed-meshheading:20820138... | lld:pubmed |
pubmed-article:20820138 | pubmed:meshHeading | pubmed-meshheading:20820138... | lld:pubmed |
pubmed-article:20820138 | pubmed:meshHeading | pubmed-meshheading:20820138... | lld:pubmed |
pubmed-article:20820138 | pubmed:meshHeading | pubmed-meshheading:20820138... | lld:pubmed |
pubmed-article:20820138 | pubmed:meshHeading | pubmed-meshheading:20820138... | lld:pubmed |
pubmed-article:20820138 | pubmed:meshHeading | pubmed-meshheading:20820138... | lld:pubmed |
pubmed-article:20820138 | pubmed:meshHeading | pubmed-meshheading:20820138... | lld:pubmed |
pubmed-article:20820138 | pubmed:meshHeading | pubmed-meshheading:20820138... | lld:pubmed |
pubmed-article:20820138 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20820138 | pubmed:articleTitle | [Therapeutic effect of omalizumab on 10 patients with severe persistent asthma]. | lld:pubmed |
pubmed-article:20820138 | pubmed:affiliation | Department of Respiratory Medicine, Takatsuki Red Cross Hospital. | lld:pubmed |
pubmed-article:20820138 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20820138 | pubmed:publicationType | English Abstract | lld:pubmed |